CRISPR Cas9 explained. CRISPR (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. is an RNA-guided gene-editing platform that makes use of a bacterially derived protein (Cas9) and a synthetic guide RNA to introduce a double strand break at a specific location within the genome.
Cas9 is an enzyme that snips DNA, and CRISPR is a collection of DNA sequences that tells Cas9 exactly where to snip.
- « first View: Taxonomy term
- ‹ previous View: Taxonomy term
- …
- 3 of 11 View: Taxonomy term
- 4 of 11 View: Taxonomy term
- 5 of 11 View: Taxonomy term
- 6 of 11 View: Taxonomy term
- 7 of 11 View: Taxonomy term
- 8 of 11 View: Taxonomy term (Current page)
- 9 of 11 View: Taxonomy term
- 10 of 11 View: Taxonomy term
- 11 of 11 View: Taxonomy term
- next › View: Taxonomy term
- last » View: Taxonomy term
The cancer moonshot aims to end cancer as it is known today. One of the key discoveries in that effort is CRISPR/Cas9 pioneered by Jennifer Doudna.
Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the
Scientists at the University of California, Berkeley and Massachusetts General Hospital have identified a key region within the Cas9 protein that governs how accurately CRISPR-Cas9 homes in on a target DNA sequence, and have t
CRISPR is the cheapest, simplest, and most effective way of manipulating DNA. It has the power to give us the cure to HIV, genetic diseases, and some cancers. It could even help address the world's hunger crisis. But, it may result in unforeseen consequences. The technology could lead to intentionally mutating embryos to create "better" humans. Jennifer Doudna, whose research...
Jennifer Doudna and Feng Zhang have received separate grants from the National Human Genome Research Institute for CRISPR technology-based projects they both say have the potential to advance the tool's usefulness for human health purposes.
On Wednesday and Thursday (August 16-17, 2017) UC Berkeley welcomed about 300 people—scientists, CEOs, farmers, regulators, conservationists, and interested citizens—to its campus to
UC Berkeley is hosting a two-day conference Aug. 16-17 that will bring together farmers, doctors, patients, environmentalists, consumers, nonprofits, community leaders and scientists to discuss potential applications of CRISPR technology, ranging from human and animal health to agriculture and conservation.
The University of California, along with the University of Vienna